Point of Care

Kalorama’s Worldwide Market for Hematology, 2026-2031 sizes and forecasts global laboratory-based and point-of-care hematology testing, with vendor shares, regional breakouts, and technology trends.

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

The world runs on roughly 150 billion diagnostic tests a year—and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition quantifies that divergence with precision, tracking global procedure volumes segment by segment and region by region as the diagnostics industry completes its transition out of the pandemic era.…

Kalorama’s 30-Country IVD Market Atlas sizes and forecasts the in vitro diagnostics market across 30 key countries and 18 segments, with five-year projections through 2030 and country-level revenue data updated through June 2026.

Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…

Kalorama Information’s Point-of-Care (POC) Urinalysis and Urinalysis Drugs of Abuse Testing Market, 2025 provides an in-depth analysis of the global market for point-of-care urinalysis and drugs of abuse testing. The report examines current market dynamics, technological trends, and future growth potential, with revenue forecasts through 2029.

Point-of-care testing encompasses diagnostic procedures performed near the patient,…

Kalorama Information’s new report, Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025, provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling…

Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.

Worldwide Market for Point-of-Care…

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.